DARA Insider Trading Activity and SEC Form 4 Filings
DARA insider trading summary
No open-market insider purchases or sales of DARA BioSciences, Inc. (DARA) have been reported on SEC Form 4 in the past 12 months.
Latest DARA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 3, 2013 | Christopher G Clement | President | Buy | $10K (14,000 @ $0.71) |
| May 30, 2013 | Haywood D Cochrane | Director | Buy | $7K (10,000 @ $0.70) |
| May 23, 2013 | Timothy James Heady | Director | Buy | $7K (10,000 @ $0.75) |
| May 17, 2013 | David Drutz | CEO and CMO | Buy | $17K (25,000 @ $0.70) |
| Sep 17, 2012 | David Drutz | CEO and CMO | Buy | $27K (25,000 @ $1.06) |
| Sep 11, 2012 | Haywood D Cochrane | Director | Buy | $2K (2,800 @ $0.82) |
| Sep 10, 2012 | Haywood D Cochrane | Director | Buy | $2K (2,200 @ $0.78) |
| Jul 20, 2012 | Haywood D Cochrane | Director | Buy | $7K (9,000 @ $0.73) |
| Jul 19, 2012 | Haywood D Cochrane | Director | Buy | $745 (1,000 @ $0.74) |
| Jun 8, 2012 | David Drutz | CEO and CMO | Buy | $19K (25,000 @ $0.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.